TFS, HealthScience

TFS HealthScience Strengthens Global Ophthalmology Unit with Strategic Hires and Integrated Delivery Model

07.08.2025 - 18:03:30 | prnewswire.co.uk

TFS HealthScience Sweden

and supporting globally executed programs, including one that recently achieved FDA approval. Ongoing trials span geographic atrophy secondary to age-related macular degeneration, diabetic macular edema, retinal vein occlusion, neurotrophic keratitis, and gene therapy programs in retinitis pigmentosa, underscoring the team's therapeutic depth and ability to support sponsors, big or small, from first-in-human development through post-marketing commitments.

TFS has also advanced innovation-forward partnerships to integrate digital technology into ophthalmic trial workflows, including a recent collaboration with RetinAI and MAXO to apply AI-driven imaging and analytics to clinical development.

As TFS continues its transformation, the ophthalmology business unit, alongside its business unit counterparts across the company, is exemplifying what's possible when strategic leadership, global infrastructure, and scientific depth align to meet the needs of today's clinical development landscape.

About TFS HealthScience
TFS HealthScience is a full-service, global Contract Research Organization (CRO) that partners with biotechnology and pharmaceutical companies to advance innovative treatments and improve patient outcomes. With operations across 50 countries, TFS and its strategic partners provide tailored strategic resourcing solutions and clinical development services in specialized therapeutic areas, including dermatologyinternal medicineneuroscienceoncology, and ophthalmology. Dedicated to empowering partners and enriching lives, TFS offers flexible solutions that combine global reach with the agility and responsiveness of a mid-sized CRO.

For more information, visit www.tfscro.com.

Logo - https://mma.prnewswire.com/media/2626111/TFS_HealthScience__Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/tfs-healthscience-strengthens-global-ophthalmology-unit-with-strategic-hires-and-integrated-delivery-model-302506550.html

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.

 <b>Hol dir jetzt den Wissensvorsprung der Aktien-Profis.</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Aktien-Empfehlungen - Dreimal die Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
boerse | 67996126 |